By Stewart Eisenhart, Emergo Group Health Canada, Canada’s medical device market regulator, has begun accepting some clinical trial-related information from sponsors via electronic submissions. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its […]
Nevro shares rise with Street-beating Q4 results
Nevro (NYSE:NVRO) reported fourth-quarter results today that beat the consensus forecast on Wall Street. The Redwood City, Calif.-based company reported losses of -$13.7 million, or -44¢ per share, on sales of $114.3 million for the three months ended Dec. 31, 2019, for sales growth of 5.9% compared with Q4 2018. Earnings per share were -44¢, 19¢ […]
Inspire Medical Systems posts Street-beating Q4 results
Inspire Medical Systems (NYSE:INSP) posted fourth-quarter results that beat the consensus on Wall Street. The Minneapolis-based company reported losses of $9.1 million, or -38¢ per share, on sales of $26.9 million for the three months ended Dec. 31, 2019, for a sales growth of 62.5% compared with Q4 2018. Earnings per share were -38¢, 2¢ ahead […]
SmileDirectClub stocks plunge amid Q4 losses
SmileDirectClub (NSDQ:SDC) today posted fourth-quarter results that missed the consensus forecast on Wall Street. The Nashville, Tenn.-based company reported losses of -$97.3 million, or -25¢ per share, on sales of $196.7 million for the three months ended Dec. 31, 2019, for a sales growth of 53.1% compared with Q4 2018. Earnings per share were -25¢, 14¢ […]
These young medtech companies raised the most money in 2019
Medical device industry insiders may very well remember 2019 as the year that IPOs came back — but another sign that the U.S. economy has left the Great Recession far behind. Among the top investment deals in the space, half involved public offerings, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Total investments […]
Abbott wins CE Mark for ICD device
Abbott (NYSE:ABT) this week announced it received CE Mark for its Gallant implantable cardioverter-defibrillator and cardiac resynchronization therapy defibrillator devices. The Gallant ICD and CRT-D devices feature Bluetooth connectivity and an accompanying smartphone app to enable patient engagement and remote monitoring. The devices also feature improved battery longevity and MRI compatibility. ICDs are often recommended to […]
Black History Month: This inventor laid the foundation for today’s pacemakers
Most people in medtech know of Earl Bakken’s contributions to pacemakers and cardiac rhythm devices, but without Otis Boykin, pacemakers wouldn’t have the pacing technology they do today. Boykin, an African-American inventor and engineer, had a special interest in resistors. His mother died from heart failure when he was 1 year old. Thirty-one years later, […]
Baxter completes Seprafilm acquisition
Baxter (NYSE:BAX) today said it completed the acquisition of Seprafilm Adhesion Barrier and its assets from Sanofi in a deal worth $350 million. Seprafilm is used as an adjunct to reduce the incidence, extent and severity of adhesions in pelvic and abdominal surgeries, according to the company. It is commercially available in the U.S., Japan, […]
Eitan Group appoints new Q Core Medical CEO
Eitan Group today said it appointed Igal Shany as CEO of its Q Core Medical and president of Eitan Group. Shany has previously served on the board of directors for Q Core and sites on the board for Eitan’s other infusion companies Sorrel Medical and Avoset Health. “I’ve had the pleasure of working with Eitan Group […]
Onkos Surgical launches bone scaffolding technology
Onkos Surgical recently launched its GenVie Magnesium Bone Scaffold. The GenVie is a magnesium-based bone void filler with osteoconductive and high compression strength attributes to promote bone repair and regeneration. It is designed for surgically created osseous defects or osseous defects created from traumatic injury to the bone. “We are excited about the launch of […]
Abiomed beats on earnings, misses on revenue in Q3 results
Abiomed (NSDQ:ABMD) posted third-quarter results that beat the earnings consensus on Wall Street, but missed on revenue. The Danvers, Mass.-based company reported profits of $69.2 million, or $1.51 per share, on sales of $221.6 million for the three months ended Dec. 31, 2019, for a bottom-line gain of 54.3% sales growth of 10.5% compared with Q3 […]